CWA Asset Management Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$290K Buy
+749
New +$278K 0.01% 601
2026
Q1
Sell
-1,091
Closed -$382K 696
2025
Q4
$382K Buy
1,091
+62
+6% +$21K 0.01% 502
2025
Q3
$333K Buy
1,029
+459
+81% +$143K 0.01% 539
2025
Q2
$222K Sell
570
-118
-17% -$47.5K 0.01% 601
2025
Q1
$299K Buy
+688
New +$276K 0.01% 514
2024
Q4
Sell
-901
Closed -$469K 587
2024
Q3
$469K Buy
+901
New +$481K 0.02% 374
2024
Q1
$426K Buy
821
+190
+30% +$94.5K 0.03% 340
2023
Q4
$298K Buy
+631
New +$292K 0.02% 333

Other funds holding ELV

CWA Asset Management Group's ELV Position: Q2 2026 in Review

CWA Asset Management Group opened a new position in Elevance Health (ELV) in Q2 2026: 749 shares worth $290K. The stake represents 0.01% of the portfolio and ranks #601 among its holdings. This is a return to the name: CWA Asset Management Group previously reported a position in ELV as recently as Q4 2025.

CWA Asset Management Group first reported a position in ELV in Q4 2023 and has held it in 8 quarters since. The position peaked at $469K in Q3 2024. 466 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • CWA Asset Management Group held 749 shares of Elevance Health worth $290K as of Q2 2026.
  • Elevance Health was a new CWA Asset Management Group position in Q2 2026.
  • Elevance Health made up 0.01% of CWA Asset Management Group's portfolio in Q2 2026, its #601 holding.
  • CWA Asset Management Group first reported a position in Elevance Health in Q4 2023 and has held it in 8 quarters since.
  • CWA Asset Management Group's Elevance Health position peaked at $469K in Q3 2024.
  • 466 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on CWA Asset Management Group's 13F filing for Q2 2026, filed 14 Jul 2026.